COMMUNIQUÉS West-GlobeNewswire

Caelum Biosciences Announces Complete Cardiac Data Analysis from Phase 1b Trial of CAEL-101 in AL Amyloidosis
25/06/2018
Nine of 10 cardiac patients on CAEL-101 showed improvement in global longitudinal strain CAEL-101 led to sustained decrease in NT-proBNP levels Data presented at American Society of Echocardiography 29th Annual [...]
PolarityTE Added to Russell 3000® and Russell 2000® Indexes
25/06/2018
SALT LAKE CITY, June 25, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (COOL), a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of patients by discovering, designing [...]
ADMA Biologics Added to the Russell 3000 and Russell 2000 Indexes
25/06/2018
RAMSEY, N.J. and BOCA RATON, Fla., June 25, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA), a vertically integrated commercial biopharmaceutical company that manufactures, markets and develops specialty [...]
Zafgen Set to Join Russell 3000® Index
25/06/2018
BOSTON, June 25, 2018 (GLOBE NEWSWIRE) -- Zafgen, Inc., (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company leveraging its proprietary MetAP2 biology platform to develop novel therapies for patients affected by [...]
Novo Nordisk A/S - Share repurchase programme
25/06/2018
Bagsværd, Denmark, 25 June 2018 - On 4 May 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR [...]
Medtronic Receives CE Mark for MiniMed(TM) 670G Hybrid Closed Loop System
25/06/2018
DUBLIN - June 25, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received CE (Conformité Européenne) Mark for the MiniMed(TM) 670G hybrid closed loop system - the first [...]
Helius Medical Technologies, Inc. Joins Russell 3000® Index, Russell 2000® Index and Russell Microcap® Index
25/06/2018
NEWTOWN, Pa., June 25, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, announced today that the [...]
EyePoint Pharmaceuticals Announces Stockholder Approval of Second Tranche of Capital Financing
25/06/2018
Expected closing of $25.5 million in capital to be used to accelerate EyePoint’s transformation into a commercial-stage specialty biopharmaceutical company Financing supports two near-term product launches anticipated [...]
Unum Therapeutics Joins Russell 3000® Index
25/06/2018
CAMBRIDGE, Mass., June 25, 2018 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (Nasdaq:UMRX), a clinical-stage biopharmaceutical company focused on the development of cellular immunotherapies based on its novel, universal [...]
Allergy Therapeutics announces publication of data demonstrating long-lasting efficacy of Pollinex Quattro Grass vaccine in Immunotherapy
25/06/2018
Allergy Therapeutics plc (“Allergy Therapeutics” or the “Group”) Allergy Therapeutics announces publication of data demonstrating long-lasting efficacy of Pollinex Quattro Grass vaccine in Immunotherapy 25 June 2018 [...]
BeyondSpring’s Principal Investigator in China for Chemotherapy-Induced Neutropenia Delivered Keynote Presentation at 12th Annual Chinese Symposium on Medical Oncology and 7th Annual Meeting of the Chinese Association for Clinical Oncologists
25/06/2018
China Chairman of NCCN Guidelines for Neutropenia Management, Dr. Yuankai Shi, Presented Positive Clinical Data Update on BeyondSpring’s Lead Asset, Plinabulin NEW YORK, June 25, 2018 (GLOBE NEWSWIRE) -- BeyondSpring [...]
Easton Pharmaceuticals Strengthens its Board of Directors While Enhancing Existing Businesses and Moves Towards New Sectors and Industries
25/06/2018
TORONTO, ON, June 25, 2018 (GLOBE NEWSWIRE) -- Easton Pharmaceuticals Inc. (OTC:EAPH) is pleased to announce the appointment of Mr. Panagis (“Panos”) Alivizatos, to its Board of Directors to enhance existing businesses [...]
International Stem Cell Corporation Publishes Advanced Stem Cell Therapy Methodology in Stem Cells and Development Journal
25/06/2018
CARLSBAD, Calif., June 25, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ( www.internationalstemcell.com ) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company [...]
REMINDER: Zafgen to Host ZGN-1061 Phase 2 Data Conference Call
25/06/2018
BOSTON, June 25, 2018 (GLOBE NEWSWIRE) -- Zafgen, Inc. , (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company using its proprietary knowledge of MetAP2 systems biology to help patients affected by a range of [...]
Nancy J. Wysenski Joins Dova Pharmaceuticals’ Board of Directors
25/06/2018
DURHAM, N.C., June 25, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ:DOVA) today announced that Nancy J. Wysenski will join Dova’s Board of Directors effective immediately. In addition to her board [...]
Kiniksa Pharmaceuticals, Ltd. Announces Exercise of the Underwriters’ Option to Purchase Additional Shares
25/06/2018
HAMILTON, Bermuda, June 25, 2018 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq:KNSA) (“Kiniksa”), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing [...]
Prodigy Health announces the launch of Prodigy Connect Real Time Inventory Management for High Value Specialty Pharmaceuticals
25/06/2018
AUSTIN, Texas, June 25, 2018 (GLOBE NEWSWIRE) -- Prodigy Health, a national specialty drug distributor that is leveraging innovative technology solutions for managing specialty pharmaceuticals in the hospital supply [...]
Veritas Appoints Mr. Filios Theodorou as Its Agent for Cyprus and SEMEA Countries
25/06/2018
VANCOUVER, British Columbia, June 25, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that Mr. Filios Theodorou has been appointed [...]
PledPharma establishes a Scientific Advisory Board for the continued clinical development of Aladote®
25/06/2018
PledPharma (publ) announces today that internationally leading experts will join a newly established Scientific Advisory Board to support the continued global clinical development of Aladote ® – a drug candidate being [...]

Pages